Neuralink, founded by Elon Musk, has received FDA approval to implant an updated brain chip in a second human patient.

The updated N1 chip addresses issues with wire breakdowns observed in the initial trial.

The redesigned chip aims to prevent wires from falling out of the brain and enables device control through thoughts.

This technology is particularly beneficial for paralyzed individuals.

Neuralink plans to implant the chip in another patient in June and aims for a total of ten patients by year-end.

Despite criticism for animal testing, the company continues to innovate in brain implant technology with Musk's support.

Musk envisions a future where two chips could potentially restore spinal nerve functionality in paralyzed individuals.